Clinical Trials on Hematological Malignancies B in New Zealand
Total 3698 results
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
BeiGeneCompletedB-cell MalignanciesUnited States, Korea, Republic of, Australia, New Zealand, United Kingdom, Italy
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
BeiGeneRecruitingMature B-Cell MalignanciesUnited States, Italy, Australia, New Zealand, Spain, Germany, United Kingdom
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingPart 1：r/r B-cell Malignancies | Part 2：B-cell MalignanciesUnited States, Poland, Israel, Ukraine
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
Incyte CorporationActive, not recruitingB-cell MalignanciesUnited States
-
Incyte CorporationCompleted
-
MedImmune LLCCompletedCancer | B-cell MalignanciesUnited States, Italy, Belgium, Canada, Spain
-
BeiGeneCompletedB-cell MalignanciesAustralia
-
Esanex Inc.Completed
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Molecular Templates, Inc.TerminatedLeukemia, Lymphocytic, Chronic, B-Cell | Diffuse Large B Cell Lymphoma | Blood Cancer | Hematological Malignancy | Small Lymphocytic Leukemia | Non-Hodgkin's B-cell LymphomaUnited States, Canada, Georgia, Belarus, Spain, Israel, Moldova, Republic of, Poland, Serbia, Ukraine
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, China, Japan, Taiwan, Australia, Germany
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Alios Biopharma Inc.TerminatedHepatitis B | Chronic Hepatitis B | Viral Hepatitis BNew Zealand
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
BeiGeneRecruitingB-cell MalignanciesChina, Italy, United States, Spain, United Kingdom, Poland, Czechia, Netherlands, Greece, France, Sweden, Korea, Republic of, Turkey
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Sanjay MohanAbbVie; Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
SynthekineRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | NHL | CLL/SLL | Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Effector TherapeuticsTerminated
-
IncuronTerminatedHematological MalignanciesUnited States
-
Assembly BiosciencesCompleted
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
Arrowhead PharmaceuticalsTerminated
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
Gilead SciencesCompleted
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingHematologic MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia (CLL) | Refractory | RelapsedUnited States